Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MIRM
#1167
Mirum Pharmaceuticals, Inc. Common Stock
92.290
0
+0.51%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.51%
Monthly Change
-8.40%
6 month change
+31.60%
Year Change
+31.60%
Previous Close
91.820
0
Open
92.110
0
Bid
Ask
Low
92.110
0
High
92.290
0
Volume
133
Markets
US Stock Market
Healthcare
MIRM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
30.42 M
31.73 M
37.95 M
47 M
49.01 M
60.34 M
—
Valuation ratios
Enterprise value
389.04 M
474.76 M
703.69 M
1.12 B
1.8 B
4.47 B
12.3 B
Price to earnings ratio
—
—
-4.8
-7.5
-22.35
-168.06
-325.38
Price to sales ratio
—
—
8.5
6.59
5.83
7.61
26.96
Price to cash flow ratio
—
—
5.45
17.3
190.32
71.03
-261.54
Price to book ratio
—
—
4.61
4.94
8.71
12.6
21.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.43
-0.29
-0.38
-0.25
-0.13
-0.03
-0.03
Return on equity %
-0.6
-0.7
-0.96
-0.66
-0.39
-0.07
-0.09
Return on invested capital %
-2 442.39
-1 010.86
-339.27
-197.68
-125.01
-28.12
-34.74
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-906.12
-170.28
-58.57
-26
-4.25
-22.53
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
-438.85
-176.05
-87.68
-26.1
-4.48
-19.4
Liquidity ratios
Quick ratio
—
3.88
2.85
4.19
2.93
2.55
11.73
Current ratio
12.8
3.91
2.94
4.45
3.1
2.67
12.33
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.24
0.37
0.51
0.69
0.7
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.47
0.46
0.37
1.63
Long term debt to total equity ratio
—
—
—
1.23
1.37
0.98
4.58
Per share metrics
Operating cash flow per share
—
—
-3.54
-1.74
0.22
1.11
1.02
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.46
7
5.9
7.64
26.03
Net current asset value per share
—
—
5.6
9.48
8.27
10.95
37.78
Tangible book value per share
—
—
2.44
-0.1
-0.51
1.07
2.26
Working capital per share
—
—
3.69
7.35
5.6
6.85
25.35
Book value per share
—
—
4.18
6.08
4.75
6.27
21.3
News
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Leerink cuts Mirum Pharmaceuticals stock price target to $118
Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform
Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)
Citizens cuts Mirum Pharmaceuticals stock price target on valuation
Mirum Pharmaceuticals earnings missed by $0.08, revenue topped estimates
Mirum Pharmaceuticals earnings up next as pipeline readouts loom
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
ImmunityBio (IBRX) Moves 41.9% Higher: Will This Strength Last?